Fund Holdings — GENERAL ATLANTIC, L.P.

Total Portfolio Value
$2.87B
Total Bought
$349.06M
Total Sold
$797.37M
Net Transaction
-$448.31M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CHIME(CHYM)19,208,76021,259,683+2,050,923387,441535,10618.63%+147,666
REVOLUTION MEDICINES(RVMD)2,474,4282,812,928+338,500115,556224,0507.80%+108,494
NURIX THERAPEUTICS(NRIX)04,897,159+4,897,159092,8993.23%+92,899
PHARVARIS
COM
8,031,2528,031,2520200,380222,8677.76%+22,488
RISKIFIED(RSKD)5,324,9985,324,998024,92126,4650.92%+1,544
GROVE COLLABORATIVE(GROV)2,474,8592,474,85903,7122,7220.09%-990
EUROPEAN WAX CENTER
CLASS A COM
13,110,49213,110,492052,31147,1981.64%-5,113
ALUMIS1,297,5300-1,297,5305,1770—-5,177
DLOCAL(DLO)46,656,69546,656,6950666,258659,72622.97%-6,532
ADAGENE3,782,3390-3,782,3397,5270—-7,527
ALKAMI(ALKT)11,991,48011,991,4800297,868276,6439.63%-21,225
ROYALTY PHARMA(RPRX)1,500,0000-1,500,00052,9200—-52,920
CENTESSA PHARMACEUTICALS9,681,8186,117,715-3,564,103234,784153,0045.33%-81,780
WEBULL(BULL)7,198,86750,816-7,148,051106,4713950.01%-106,076
XP, INC(XP)25,517,73322,699,133-2,818,600479,478371,58512.93%-107,893
ALIGNMENT HEALTHCARE(ALHC)24,287,22713,167,733-11,119,494423,812260,0639.05%-163,749
AKERO THERAPEUTICS5,733,9890-5,733,989272,2500—-272,250
Page 1 of 1
GENERAL ATLANTIC, L.P. — 13F Holdings — Q4 2025 | TickerTrail